Glucotrack announces preclinical testing with implantable continuous glucose monitor

Rutherford, nj, oct. 12, 2023 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has achieved another milestone in its development of an implantable continuous glucose monitor (cgm) by commencing preclinical animal testing.
GCTK Ratings Summary
GCTK Quant Ranking